Dr Daniel Grint
BSc MSc PhD
of Medical Statistics & Epidemiology
I co-organise (with Sian Floyd) the distance learning module EPM304 (Advanced Statistical Methods in Epidemiology). I also teach on the in-house courses Statistics for Epidemiology and Population Health (STEPH), Statistical Methods in Epidemiology (SME) and Advanced Statistical Methods in Epidemiology (ASME).
I am a member of the International Statistics & Epidemiology Group (ISEG) and am also currently working with the OpenSafely group. My research focuses on the design, implementation and analysis of randomised clinical trials, along with analysis of electronic health records.
I am the trial statistician on the RIFASHORT trial. This trial with sites in Botswana, Uganda, Guinea, Peru, Nepal, and Pakistan aims to assess the efficacy and saftey of 4-month high-dose rifampicin treatment regimens for TB. I am statistical adviser and co-supervisor to Fiona Cresswell on the RIFT trial. This trial aims to assess the safety of high-dose oral and intravenous rifampicin for treatment of TB meningitis in Uganda.
I serve as an independant statistician on the Data Safety and Monitoring Boards (DSMB) for two trials of TB treatment. The SIMPLICITB and BEAT TB trials are both assessing the efficacy and safety of 6-month regimens for treatment of drug-resistant TB.
I am analysing electronic health record data from UK general practices to test hypotheses relating to COVID-19 and inform pandemic modelling studies.